Table 2.
clinical characteristics of patients with non-viral liver carcinoma.
| Characteristics | |
|---|---|
| Gender (male/female) | 12/6 |
| Age (years) | 69.1 (49–83) |
| Primary or metastatic | |
| Primary | 9 |
| Metastatic | 9 |
| Child–Pugh (A/B/C) | 17/1/0 |
| AST (IU/L) | 30.1 (17–52) |
| ALT (IU/L) | 24.4 (11–55) |
| LDH (IU/L) | 287.1 (137–1284) |
| Cholinesterase (IU/L) | 224.8 (110–285) |
| γ-GTP (IU/L) | 90.8 (14–268) |
| Total protein (g/dL) | 6.8 (2.0–8.2) |
| Albumin (g/dL) | 3.8 (2.8–4.5) |
| Total bilirubin (mg/dL) | 0.7 (0.4–0.9) |
| Platelet (× 104/μL) | 20.9 (7.6–26.6) |
| Prothrombin time (%) | 95.5 (75–100) |
| ICG at 15 min (%) | 17 (5–39) |
| Alcohol (yes/no/unknown) | 9/6/3 |
| Smoking (+/−/unknown) | 6/9/3 |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; γ-GTP, γ-glutamyltranspeptidase; ICG, indocyanine green test.